Latest IPO Information

Goldline Pharmaceutical Ltd. IPO

IPO Date: May 12 to May 14 2026

Listing Date: May 19 2026

Objective

1. Prepayment or repayment of all or a portion of certain outstanding borrowings availed by our Company; and
2. General corporate purposes.

IPO Details

Face Value ₹ 10.00 Per Share
Issue Size ₹ 8.07 - 8.46 Cr
Price Band ₹ 41.00 - ₹ 43.00 Per Share
Market LOT 6000 shares
Issue Type Book building

About Company

We are engaged in the business of marketing pharmaceutical products under the brand name “Goldline.” Our product portfolio is organized into five distinct segments: Goldline Pharma, Goldline Cardinal, Goldline Aayushman, Goldline InLife, and Goldline Wellness. The pharmaceutical products marketed under the “Goldline” brand are not manufactured by our Company. Instead, we enter into contractual arrangements with third-party manufacturers, who produce the products based on our market research, demand analysis, and specifications. These contractual arrangements ensure that all products meet the r .... equisite quality standards and regulatory norms.The products are marketed and sold exclusively under the “Goldline” brand. Our customers primarily comprise distributors, who further supply to retailers and wholesalers, forming the main channel of distribution to the end-users. Presently, we maintain contractual arrangements with 15 manufacturers and 7 distributors, ensuring a stable supply chain and consistent market presence.Our Company also extend comprehensive material supply and procurement support to hospitals and healthcare partners. Through our promoter group entities as Numerius Healthcare Pvt Ltd (Formerly Known As Enrich Healthcare & PSPL International) & Activista Healthcare Pvt Ltd (Formerly Known As Gold N Gold Distributors). Our Company manage trading and supply chain operations, thereby ensuring reliable procurement, seamless distribution, and logistical efficiency.Our Promoters, Mr. Amol Laxmikant Mujumdar and Mr. Swapan Premprakash Khandelwal, with 25 years and 30 years of experience respectively in pharmaceutical marketing and supply chain management, have been instrumental in shaping the growth and strategic direction of the Company. Their expertise continues to drive our business expansion and operational resilience. Read More
Address

103, F-1, Leela Apartment Near Shanidham, Shilpa Society Saptagiri Nagar

City

Nagpur

State

Maharashtra

Pincode

440015

Phone

712-2786666 / 9561132666

Email

info@goldlinepharma.in

Website

www.goldlinepharma.in

About IPO

Listed At BSE
Lead Manager Cumulative Capital Pvt Ltd
Promoters
Swapan Premprakash Khandelwal
Amol Laxmikant Mujumdar

Promoter's Holding

Registrar

Bigshare Services Pvt Ltd

Latest News

Nov
11
2026
EQUITY Posted on Nov 11th 2026

Somany Ceramics informs about earnings call transcript

Somany Ceramics has enclosed the Transcript of the Earnings Conference Call held on Thursday, 5th November, 2026 regarding the Financial Performance of the Company for the quarter and half year ended 30th September, 2026. The aforesaid information may also be accessed on the website of the Company at www.somanyceramics.com.
The above information is a part of company’s filings submitted to BSE.
Read More
Nov
11
2026
EQUITY Posted on Nov 11th 2026

Hariom Pipe Industries informs about earnings call transcript

Pursuant to Regulation 30 and 46 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Hariom Pipe Industries has enclosed the transcript of the Post-Earnings Conference Call held with the Investors/Analysts on November 05, 2026, on the Unaudited Financial Results/ Financial and Operational Performance of the Company for the quarter and half year ended September 30, 2026. The aforesaid transcript is also available on the Company’s website at https://www.hariompipes.com/presentations-made-to-analysts-or-institutional-investors.
The above information is a part of company’s filings submitted to BSE.
Read More
Nov
11
2026
EQUITY Posted on Nov 11th 2026

Navneet Education informs about transcript of earnings call

In accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Navneet Education has submitted the transcript of the earnings call held on Thursday, 05th November, 2026 with investors and analysts to discuss the Operational and Financial performance of the Company for Q2FY27. The company has also informed that the said transcript is available on the website of the Company www.navneet.com.

The above information is a part of company’s filings submitted to BSE.

Read More
Nov
11
2026
EQUITY Posted on Nov 11th 2026

Lakshmi Engineering And Warehousing informs about outcome of board meeting

Lakshmi Engineering And Warehousing has informed that the Board of Directors of the Company at their meeting held on 11.11.2026, had considered and approved the following: 1. The Unaudited Financial Results (Standalone) for the quarter ended 30.09.2026 in the prescribed format. 2. The Limited Review Report of the Auditors for the period ended 30.09.2026. The Board Meeting commenced at 11.55 AM and concluded at 1.05 PM on 11.11.2026.

The above information is a part of company’s filings submitted to BSE.

Read More
Nov
11
2026
EQUITY Posted on Nov 11th 2026

Kalpataru Projects International submits analyst meet intimation

Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Kalpataru Projects International has informed that the schedule of Analyst / Institutional Investor Meet to be attended by the Company on 16th and 17th November, 2026.
The above information is a part of company’s filings submitted to BSE.
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the issue size of Goldline Pharmaceutical Ltd. IPO?

The issue size of Goldline Pharmaceutical Ltd. IPO is ₹8.07 - 8.46 crore.

The Goldline Pharmaceutical Ltd. IPO opens for subscription on 2026-05-12 and closes on 2026-05-14.

The price range of Goldline Pharmaceutical Ltd. IPO is ₹41.00 to ₹43.00.

The lot size of Goldline Pharmaceutical Ltd. IPO is 6000 shares.

The registrar of Goldline Pharmaceutical Ltd. IPO is Bigshare Services Pvt Ltd .

Goldline Pharmaceutical Ltd. IPO will be listed on BSE .

You will typically receive a confirmation message or notification from your broker or trading platform shortly after placing your IPO order. This confirms that your application has been submitted successfully. You can also check the order status in the IPO section of your trading account or app.

Apply early with valid UPI and PAN before 2026-05-14 to increase your chances.

The listing date of Goldline Pharmaceutical Ltd. IPO is 2026-05-19.

An Initial Public Offering (IPO) is when a private company sells shares to the public for the first time, enabling investors to purchase these shares and gain partial ownership in the business. For instance, if a well-known tech firm wants to grow and requires additional funds, it might choose to go public through an IPO. During this process, investors can buy shares, and the company’s stock starts trading on the stock exchange on the day of the IPO listing.

Investors can apply for an IPO through their bank or brokerage account. Many trading platforms have a specific section for IPOs where users can submit their applications online.

The primary market is where shares are offered to the public for the first time via an IPO. After the IPO, shares are traded on the secondary market (stock exchange), where existing shareholders can sell to new buyers.

Investing in an IPO offers the opportunity to become an early investor in companies with high growth potential, at a price which may be lower than their post-listing market value. It provides a chance to participate in the company's growth journey from its early stages. However, IPO investments also come with inherent risks, such as market volatility and uncertainties about the company's future performance.

The price of an IPO is established through a systematic process known as "book building." In this method, investors bid within a given price range, and the final price is set based on demand and market conditions. Several factors play a crucial role in determining the IPO price, including:

Past Financial Performance: Evaluating the company's revenue, profits, and financial stability over time

Growth Potential: Assessing future prospects based on the company's business model and market opportunities

Industry Peers: Comparing valuation metrics with similar companies in the same sector

Larger Industry Picture: Analysing overall industry trends and economic conditions that could impact the company's performance

The lock-in period for IPO shares refers to a duration during which specific investors are restricted from selling their shares post-listing. This period varies based on the type of investor:

Promoters: The lock-in period for promoters ranges from 6 months to 18 months, ensuring their commitment to the company's long-term growth

Anchor Investors: Typically, anchor investors face a shorter lock-in period of 30 to 90 days, depending on regulatory norms and the specific IPO

IPOs can be volatile and may not perform as expected in the short term. Investors risk losing capital if the stock price drops after listing, especially if the company does not meet its growth projections.

Information on upcoming IPOs is often available through brokerage platforms, financial news sites, and regulatory bodies like SEBI, which publishes details on companies going public. You can also get these details under the upcoming IPO section on Bajaj Markets.

Eligibility for an IPO typically includes:

Retail Investors: Individuals who invest in smaller amounts, usually under the “retail investor” category, with certain limits

Qualified Institutional Buyers (QIBs): Entities like mutual funds, banks, and insurance companies, who invest large sums

Non-Institutional Investors (NIIs): High-net-worth individuals or entities investing above the retail threshold

Investors must have a Demat and trading account to apply, and in some cases, certain financial or residency qualifications may apply depending on local regulations.

SME (Small and Medium Enterprise) IPOs generally carry higher risk but may provide significant growth potential. Investors should research the company’s stability, financials, and sector risks, as SME stocks can be more volatile compared to large-cap companies.

View More

Invalid Mobile Number

Invalid Full Name

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore